NCT07764029

Brief Summary

The purpose of this randomized controlled clinical trial is to compare the effectiveness of advanced platelet-rich fibrin (A-PRF+) combined with xenograft versus a collagen membrane combined with xenograft in the treatment of degree II furcation involvements in mandibular first molars. Adult patients with periodontitis will randomly receive either the A-PRF+ treatment or the collagen membrane treatment during periodontal flap surgery. The study will evaluate clinical periodontal healing, bone regeneration using 3D imaging (CBCT), patient comfort (pain levels and satisfaction), and changes in the TWEAK biomarker in gingival crevicular fluid over a 6-month period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
10mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Jun 2026Jun 2027

Study Start

First participant enrolled

June 25, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

11 months

First QC Date

August 9, 2026

Last Update Submit

August 9, 2026

Conditions

Keywords

A-PRF plusA-PRF+XenograftMandibular MolarGuided Tissue RegenerationTWEAKbiomarkercollagen membrane

Outcome Measures

Primary Outcomes (2)

  • Horizontal Clinical Attachment Level (HCAL)

    HCAL is evaluated using a Nabers probe and a customized acrylic stent to measure the horizontal penetration from the buccal furcation entrance to the deepest point of the defect

    Baseline and 6 months post-surgery

  • Probing Pocket Depth (PPD)

    PPD is measured using a UNC-15 periodontal probe and a customized acrylic stent to ensure measurement reproducibility. The measurement is recorded at the buccal aspect of the involved tooth

    Baseline and 6 months post-surgery

Secondary Outcomes (11)

  • Plaque Index (PlI)

    Baseline, 3 months, and 6 months post-surgery

  • Gingival Index (GI)

    Baseline and 6 months post-surgery

  • Vertical Clinical Attachment Level (VCAL)

    Baseline and 6 months post-surgery

  • Gingival Recession (GR)

    Baseline, 3 months, and 6 months post-surgery

  • Radiographic Vertical Bone Level (VBL)

    Baseline and 6 months post-surgery

  • +6 more secondary outcomes

Study Arms (2)

A-PRF+ and Xenograft

EXPERIMENTAL

Open flap debridement followed by the application of A-PRF+ mixed with xenograft (Cerabone), covered by an A-PRF+ membrane

Procedure: A-PRF+ and Xenograft

Collagen Membrane and Xenograft

ACTIVE COMPARATOR

Open flap debridement followed by the application of xenograft (Cerabone) covered by a resorbable collagen membrane

Procedure: Collagen Membrane and Xenograft

Interventions

Open flap debridement surgery. The furcation defect is filled with a mixture of A-PRF+ fragments and bovine xenograft (Cerabone), and then covered with an A-PRF+ membrane before suturing

Also known as: Advanced Platelet-Rich Fibrin plus, Cerabone, A-PRF+
A-PRF+ and Xenograft

Open flap debridement surgery. The furcation defect is filled with bovine xenograft (Cerabone) and covered with a resorbable collagen membrane before suturing

Also known as: Guided Tissue Regeneration, Bio-Gide, Cerabone, Collagen membrane
Collagen Membrane and Xenograft

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years old
  • Patients diagnosed with periodontitis who have completed non-surgical treatment: scaling and root planing
  • Patients attending a follow-up visit at least 5 weeks after non-surgical treatment, demonstrating compliance and good oral hygiene cooperation
  • Presence of a mandibular molar with a Degree II furcation involvement according to Hamp (1975), presenting a residual periodontal pocket at the buccal site (PPD ≥ 5mm) after non-surgical treatment, and showing radiolucency in the furcation area on CBCT imaging
  • Plaque Index (PlI) \< 1 following non-surgical treatment
  • Width of keratinized gingiva ≥ 2mm
  • Teeth with furcation defects where gingival recession does not extend apically beyond the buccal furcation fornix (no supragingival furcation exposure)
  • Teeth without occlusal trauma, pulpal or periapical pathologies, and no combined periodontic-endodontic lesions
  • Degree II furcation involvement according to Hamp (1975) and Subclass A or B according to Tarnow and Fletcher (1984)
  • The defect is located apical to the interproximal alveolar bone crest on CBCT imaging

You may not qualify if:

  • Patients with systemic diseases affecting periodontal treatment outcomes, such as: diabetes mellitus, heart disease requiring anticoagulant therapy, blood disorders, immunodeficiency, etc
  • Pregnant or lactating patients
  • Patients who have used antibiotics or any other medications affecting periodontal treatment outcomes within the last 6 months
  • Patients who smoke tobacco.
  • Patients who have used aspirin or medications affecting blood coagulation within 2 weeks prior to the blood collection for PRF preparation
  • Patients with a history of allergy to local anesthetics
  • Defects associated with grade II tooth mobility that has not been splinted, or grade III tooth mobility according to Miller (2014)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, Ho Chi Minh City (HCMC), 700000, Vietnam

RECRUITING

MeSH Terms

Conditions

PeriodontitisFurcation Defects

Interventions

Transplantation, HeterologousceraboneGuided Tissue RegenerationBio-Gide

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, OperativePlastic Surgery Procedures

Central Study Contacts

Thanh Si Ho, Doctor of Dental Surgery

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Eligible teeth are randomly assigned in parallel to either the test group (A-PRF+ and xenograft) or the control group (collagen membrane and xenograft
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor of Dental Surgery

Study Record Dates

First Submitted

August 9, 2026

First Posted

August 13, 2026

Study Start

June 25, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

August 13, 2026

Record last verified: 2026-08

Locations